Omega Funds
company
About
Omega Funds global life sciences-based investment firm specialized in direct secondary transactions.
- 11 - 50
Highlights
Details
- Industries
- Biotechnology,Venture Capital
- Founded date
- Jan 1, 2004
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- Venture Capital
Strategically advanced, they enable you to benefit from the expertise of institutional portfolio managers all for a minimum investment of $500!Omega FundsTM give you the opportunity to diversify your investment portfolio and maximize return potential.
Investments
Number of Investments
Number of Lead Investments
7
2
Omega Funds has made 7 investments. Their most recent investment was on
Jan 7, 2021, when Scorpion Therapeutics raised $162M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jan 7, 2021
Scorpion Therapeutics
|
Series B | $162M | Biotechnology | — |
|
Oct 26, 2020
Scorpion Therapeutics
|
Series A | $108M | Biotechnology | Yes |
|
Mar 6, 2019
Beam Therapeutics
|
Series B | $135M | Biotechnology | — |
|
Sep 8, 2017
Replimune Group
|
Series B | $55M | Biotechnology | — |
|
Sep 24, 2015
Replimune Group
|
Series A | $30M | Biotechnology | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
